Venkys (India) Ltd
VENKEYSVenkys (India) Ltd's earnings have outrun its stock. EPS grew +19.4% in a year against a −0.3% price move.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is in a downtrend (3 weeks in) while the P/E sits at the 32nd percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +676.9% year on year, and 101% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Venkys (India) Ltd trades at ₹1,499, in a downtrend and 3 weeks into that stage. That is +1.5% against its own 200-day average. It sits at 69% of a 52-week range of ₹1,213 to ₹1,631. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 2 straight weeks.
Today the stock is in a downtrend — week 3 of stage 4. At ₹1,499 it trades +1.5% versus its 200-day average and sits at 69% of its 52-week range (₹1,213–₹1,631).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +395% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Venkys (India) Ltd trades at 15.2× P/E, near the bottom of its own range — cheaper only 32% of the time. Its long-run median P/E is 17.8×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 15.2× is near the bottom of its own range — cheaper only 32% of the time, against a long-run median of 17.8× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +19.4% against a −0.3% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −13.5%/yr price move, ~−12.4%/yr came from earnings growth and ~−1.1 pp from the multiple (compressing); over 10y, of the +12.3%/yr price move, ~+7.9%/yr came from earnings growth and ~+4.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Venkys (India) Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +12.7% | −4.2% | +3.6% | +5.8% |
| Profit | +18.8% | +25.7% | −12.3% | +13.8% |
| EPS | +19.4% | +25.5% | −12.3% | +13.8% |
| Share price | −0.3% | −9.4% | −13.5% | +12.3% |
4-Factor Sector Score
49.3/100 — rank 2 of 5 in FMCG - Animal/Polutry · 83% evidence confidence
Venkys (India) Ltd scores 49.3 out of 100 against the 5 companies it is compared with in FMCG - Animal/Polutry, ranking 2. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.7 + 7.7 + 11.1 + 10.8 = 49.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Venkys (India) Ltd reported ₹1,100 Cr of revenue in the Mar 26 quarter, +30.5% year on year. That is the 4th straight quarter of year-on-year growth. Over 10 years it has compounded at 5.8% a year. The last full year, FY26, came in at ₹3,727 Cr. The last four reported quarters add to ₹3,727 Cr.
FY26 revenue came in at ₹3,727 Cr (+12.7% on the year), capping 10 years at 5.8% compound. The latest quarter (Mar 26) printed ₹1,100 Cr, +30.5% year on year — the 4th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +12.5% growth against the decade's 5.8% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +12.7% over the last 4 quarters against −0.1%/yr over the last 8 — accelerating; TTM profit +19.8% vs +32.6%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Venkys (India) Ltd's operating margin is 12.0% in the Mar 26 quarter, +9.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −0.7% to 14.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 12.0%, +9.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −0.7%–14.0%.
Why the margin moved: operating margin went +8.8 pp year on year while gross margin went +5.4 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Venkys (India) Ltd earned ₹101 Cr of net profit in the Mar 26 quarter, +676.9% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹139 Cr. The 10-year compound rate is 13.8%. That is 9.2% of the quarter's revenue. The same quarter a year earlier earned ₹13.0 Cr.
Mar 26 profit was ₹101 Cr, +676.9% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹139 Cr (+18.8%), and the 10-year compound rate is 13.8%.
Why profit moved: revenue contributed +30.5% and the margin +9.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +76.4% vs revenue +12.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 101% of Venkys (India) Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹191 Cr of operating cash against ₹139 Cr of profit. After ₹39.0 Cr of capital spending, ₹152 Cr was left as free cash.
FY26: operating cash of ₹191 Cr against reported profit of ₹139 Cr, leaving free cash of ₹152 Cr after ₹39.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 101% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 101%: the cash cycle stretched 29 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Venkys (India) Ltd's cash conversion cycle runs 53 days in FY26, up from 24 days in FY21. Capital spending ran ₹138 Cr over the last 3 years. At FY26 sales of ₹3,727 Cr each day of that cycle holds about ₹10.2 Cr, so roughly ₹541 Cr sits inside the business at any moment.
FY26: debtors at 53 days, inventory at 43 days — roughly 1.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 53 days, looser than FY21's 24.
The full loop: cash goes out to suppliers and production on day 0; stock waits 43 days to sell; customers pay about 53 days after that; and suppliers themselves are paid at 43 days — netting out to the 53-day cycle.
In money terms: at FY26 sales of ₹3,727 Cr, each day of the cycle holds about ₹10.2 Cr — so the 53-day loop keeps roughly ₹541 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹138 Cr over the last 3 fiscal years against ₹109 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹9.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Venkys (India) Ltd earns a ROCE of 12% in FY26. That is up from a trough of −2% in FY20. Return on invested capital clears the cost of that capital by −3.7 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.7% net margin on 1.61× asset turns.
FY26 ROCE is 12%, recovered from a FY20 trough of −2% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 3.7% net margin × 1.61× asset turns × 1.45× balance-sheet leverage ≈ 8.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 8.3% − 12.0% = a −3.7 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Venkys (India) Ltd carries total debt of ₹167 Cr against shareholder equity of ₹1,596 Cr as of Mar 26, a debt-to-equity of 0.10 — effectively unlevered. On the annual view that ratio went from 0.16 in FY22 to 0.10 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹167 Cr against shareholder equity of ₹1,596 Cr — a debt-to-equity of 0.10. On the annual view, debt-to-equity went from 0.16 (FY22) to 0.10 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Venkys (India) Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved −0.1 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.1 points over 8 quarters to 1.3%; Domestic institutions: −0.1 points over 8 quarters to 0.1%; Promoters: +0.0 points over 8 quarters to 56.1%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Venkys (India) Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1SKM Egg Products Export (India) LtdSKMEGGPROD | 76.5/100Favorable setup74% evidence | TURNING | 32.6/35 Revenue 40% · PAT 100% · OPM change 3 pp 95% evidence | 16.9/25 ROCE 30% · OPM 17% 95% evidence | 10.0/20 P/E 11.8× · PEG — 15% evidence | 17.0/20 RS sector 15.4% · RS bench 24.1% · 1Y 65.2%9 of 11 weeks ahead 70% evidence |
| Exact sum: 32.6 + 16.9 + 10 + 17 = 76.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Venkys (India) Ltdthis pageVENKEYS | 49.3/100Mixed-negative evidence83% evidence | ASLEEP | 19.7/35 Revenue 12.7% · PAT 19.8% · OPM change 9 pp 83% evidence | 7.7/25 ROCE 11.9% · OPM 12% 95% evidence | 11.1/20 P/E 15.2× · PEG — 50% evidence | 10.8/20 RS sector 3.8% · RS bench 1.9% · 1Y -3%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 7.7 + 11.1 + 10.8 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3HMA Agro Industries LtdHMAAGRO | 48.9/100Mixed-negative evidence83% evidence | ASLEEP | 24.4/35 Revenue 34.8% · PAT 88.4% · OPM change -0.7 pp 83% evidence | 9.5/25 ROCE 16% · OPM -0.4% 95% evidence | 15.0/20 P/E 6.2× · PEG — 50% evidence | 0.0/20 RS sector -23.2% · RS bench -24.7% · 1Y -32.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 9.5 + 15 + 0 = 48.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -23.2% and the one-year return is -32.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 4Godrej Agrovet LtdGODREJAGRO | 45.8/100Mixed-negative evidence78% evidence | ASLEEP | 14.7/35 Revenue 9% · PAT 10.2% · OPM change -1 pp 83% evidence | 14.4/25 ROCE 19.2% · OPM 6% 76% evidence | 11.6/20 P/E 23.2× · PEG — 50% evidence | 5.1/20 RS sector -8.7% · RS bench -10.5% · 1Y -33.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 14.4 + 11.6 + 5.1 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5KSE LtdKSE | 36.0/100Mixed-negative evidence65% evidence | ASLEEP | 3.4/35 Revenue 1.9% · PAT -8% · OPM change -13 pp 83% evidence | 14.8/25 ROCE 33.6% · OPM -1.3% 76% evidence | 10.8/20 P/E 7.4× · PEG — 15% evidence | 7.0/20 RS sector -4.2% · RS bench -12.7% · 1Y -17.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 3.4 + 14.8 + 10.8 + 7 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Venkys (India) Ltd's share price today?
Venkys (India) Ltd trades at ₹1,499, −0.3% over the past year. The company is valued at ₹2,112 Cr. The stock sits at 69% of its 52-week range of ₹1,213–₹1,631, +1.5% versus its 200-day average. On the tape, the price is in a downtrend, 3 weeks in. — as of 31 July 2026.
What were Venkys (India) Ltd's latest quarterly results?
Venkys (India) Ltd reported revenue of ₹1,100 Cr and net profit of ₹101 Cr for the Mar 26 quarter. Revenue rose 30.5% and profit rose 676.9% year on year. Earnings per share were ₹71.96. The operating margin was 12.0%, 9.0 pp higher than a year earlier. — as of 31 July 2026.
What is Venkys (India) Ltd's revenue?
Venkys (India) Ltd reported revenue of ₹1,100 Cr in the Mar 26 quarter, +30.5% year on year. For the full FY26 fiscal year, revenue was ₹3,727 Cr (+12.7%). Over the last 10 years revenue compounded at 5.8% a year. — as of 31 July 2026.
What is Venkys (India) Ltd's profit?
Venkys (India) Ltd earned ₹101 Cr of net profit in the Mar 26 quarter, +676.9% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹139 Cr. The operating margin ran 12.0% in the latest quarter. — as of 31 July 2026.
What is Venkys (India) Ltd's market cap?
Venkys (India) Ltd's market capitalisation is ₹2,112 Cr at a share price of ₹1,499. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Venkys (India) Ltd's P/E ratio?
Venkys (India) Ltd trades at a P/E of 15.2×, at the 32nd percentile of its own 10-year range, against a long-run median of 17.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Venkys (India) Ltd pay a dividend?
Yes — Venkys (India) Ltd's dividend payout was 10% of profit in FY26, and it recorded a payout in 12 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Venkys (India) Ltd overvalued?
On its own history, Venkys (India) Ltd looks cheap against its own history: its P/E of 15.2× has been cheaper only 32% of the time in 10 years (long-run median 17.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Venkys (India) Ltd growing?
Yes — Venkys (India) Ltd is growing: latest-quarter revenue +30.5% year on year, profit +676.9%, and the margin +9.0 pp at 12.0%. The 10-year compound rates are 5.8% (revenue) and 13.8% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Venkys (India) Ltd performing?
Venkys (India) Ltd is in a downtrend, 3 weeks in. Its latest quarter's revenue rose 30.5% and profit rose 676.9% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Venkys (India) Ltd in an uptrend?
No — the price is in a downtrend (week 3 of stage 4), trading +1.5% versus its 200-day average and at 69% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Venkys (India) Ltd beating the market?
On recent form, yes — Venkys (India) Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +395% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Venkys (India) Ltd's share price go up?
This page publishes no price forecast for Venkys (India) Ltd. What it measures instead: the share price is ₹1,499, the price is in a downtrend 3 weeks in. Its P/E of 15.2× sits at the 32nd percentile of its own 10-year range. — as of 31 July 2026.
Who owns Venkys (India) Ltd?
Promoters hold 56.1% of Venkys (India) Ltd, foreign institutions 1.3%, domestic institutions 0.1% and the public 42.5% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does Venkys (India) Ltd have too much debt?
No — Venkys (India) Ltd's debt-to-equity is 0.10, and operating profit covers the interest bill 11×. FY26 borrowings were ₹167 Cr against equity of ₹1,596 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is Venkys (India) Ltd's capex?
Venkys (India) Ltd spent ₹138 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹39.0 Cr, with ₹9.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Venkys (India) Ltd's cash flow?
Venkys (India) Ltd generated ₹191 Cr of operating cash flow in FY26 and ₹152 Cr of free cash flow after ₹39.0 Cr of capital spending. Reported profit that year was ₹139 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Venkys (India) Ltd's profit real cash?
Yes — over the last 3 fiscal years, 101% of Venkys (India) Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹191 Cr against reported profit of ₹139 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Venkys (India) Ltd in its business cycle?
Venkys (India) Ltd's FY26 operating margin was 5.0%, against a 13-year band of −0.7%–14.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 12.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Venkys (India) Ltd story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Venkys (India) Ltd a stock worth studying right now?
This is not investment advice. The machine read: Venkys (India) Ltd's earnings have outrun its stock. EPS grew +19.4% in a year against a −0.3% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.